Clinical trials of the AstraZeneca vaccine are still in progress.
Copyright 2020 The Associated Press. All Rights Reserved
Swiss drug authority Swissmedic has begun evaluating the so-called “Covid-19 Vaccine AstraZeneca”. It is the first time that a drugmaker has presented a coronavirus vaccine for approval in Switzerland.
AstraZeneca, which developed the vaccine in collaboration with the University of Oxford, submitted its application to Swissmedic at the start of this month.
The vaccine’s scientific evaluation will be done via a “rolling submission” process. This allows a pharmaceutical company to launch the application procedure before a product’s development is complete.
This “enables Swissmedic to carry out the scientific assessment of non-clinical data from laboratory tests while clinical trials are still in progress,” announced Swissmedic in a statement on Tuesday, noting that trial results must be submitted for scientific review as they become available over the next weeks and months.
More
More
Half of Swiss would get vaccinated against Covid-19
This content was published on
If there were an efficient vaccination against coronavirus, every second person in Switzerland would take it, says a survey.
“However, no decision on authorisation can be taken until all the data needed to assess the safety, quality and efficacy of the vaccine have been submitted. The documentation must demonstrate how safe and effective the vaccine is in protecting humans against the new SARS-CoV-2 coronavirus,” wrote the Swiss drug authority.
Swissmedic noted that while it is reviewing the vaccine independently, it is also working closely with partner authorities abroad. No medicinal product can go onto the Swiss market without Swissmedic’s approval.
More
More
Coronavirus: the situation in Switzerland
This content was published on
An overview of the latest Covid-related information in the Alpine nation.
Has your continent reached its peak or is there still potential for economic growth?
Some regions of the world are on an upward trajectory with the promise of a steadily improving future. Where do you live? And in which direction is your region or continent developing?
Switzerland testing AI tools to make scarecrows more effective
This content was published on
The Swiss agricultural research centre Agroscope is testing an AI system to more effectively prevent damage to agricultural crops caused by crows and rooks.
UN in Geneva calls for reform of tariffs on plastics
This content was published on
The United Nations is calling for a reform of customs tariffs on plastics, which are lower than those imposed on alternatives, ahead of negotiations for a treaty to limit plastic pollution.
Two robots play hide-and-seek in space with Swiss help
This content was published on
Robots developed separately have worked together at the International Space Station (ISS) for the first time, helped in part by a control centre in Switzerland.
Giant Swiss flag torn by the wind at the foot of mountain
This content was published on
A giant Swiss flag tore as it was rolled out on a grassy slope at the foot of a mountain ahead of August 1 National Day celebrations.
Swiss scientists reveal the complex craft of prehistoric tattooing
This content was published on
An international research team led by the University of Bern has analysed tattoos on a Siberian glacial mummy that is over 2,000 years old.
Swiss National Bank posts CHF15 billion loss in first half of the year
This content was published on
The Swiss National Bank (SNB) slipped into the red in the first half of 2025 due in particular to the weakening US dollar.
Exiled Russians criticise visit of sanctioned Russian politicians to Geneva
This content was published on
Around 200 Russian opposition figures have sent an open letter protesting the presence of sanctioned Russian politicians in Geneva.
Switzerland pre-orders 4.5 million doses of Covid-19 vaccine
This content was published on
The Swiss government has signed a deal with US biotech firm Moderna to secure early access to 4.5 million doses of a Covid-19 vaccine currently in development.
Switzerland fast-tracks antiviral medication against Covid-19
This content was published on
Swissmedic, the agency that oversees the use of medicaments in Switzerland, took days to fast-track approval of the drug, which is produced under the brand name Veklury by US biopharmaceutical company Gilead Sciences. The application for its extended use was only received on Monday. It can now be used for a limited period of time to…
Join the conversation!